RECEPTOL® in Disaster Relief

RECEPTOL® in Disaster Relief

By PROF. RALPH FOSTER, M.D., M.P.H.

Our public health community is in an enviable position today of having the ability to provide biotech products and services to prevent and reduce infectious disease as major health concerns for the Tsunami survivors.

Globalceuticals, Inc. is committed to bringing the discovery of informational proteins into the public domain in the form of RECEPTOL^®; a biotech product that reorients the system of the body to support wellness, by normalizing mammal cellular function, provides stoichometric hindrance to viruses at the cellular surface to prevent viruses attaching to cell surfaces, and when needed induce recovery. 

Recently, the SARS virus was a high profile disease in China.  SARS is a virus, like many other viruses can be treated successfully with RECEPTOL.  The RECEPTOL^® software includes an uncounted number of ligand protein units all designed to key into cellular receptor sites and block viruses from attaching to human cells.  Exploration of new health possibilities becomes essential to making a difference in the quality of people's lives.

To date RECEPTOL^® (infopeptide supplementation) is indicated for the prevention and reduction of: Tuberculosis, Acute and chronic viral infections (HAV, HCV, HIV, SARS, Mononucleosis, Colds, Flus, and Rabies), Allergies, Thrush, Viral and Bacterial Pharyngitis, Celiac Sprue, Kuru (Prion Disease), topical applications (burns, infections, and insect bites). The world needs a more effective method of response to life threatening infectious diseases that is:

• Broadly effective with ancillary effect against a wide range of opportunistic infections
• Safe under all circumstances including extended use
• Without the prospect for eventual resistance
• Practical, palatable and easy to administer
• Compatible with other treatments
• Compatible with religious and cultural sensitivities
• Universally available
• Priced appropriately in all markets
• Available to the poor with assistance from non-profit organizations

Ralph Foster, a professor of health sciences at the University of Phoenix, has 25+ years experience in immunological research, as well as in NIAID, NIH Conference presentations.  He has had international, hands on experience in medicine, and public health.  He is currently located in San Miguel, California.